journal article·2019-12-04Open access

Mechanism of miR-143-3p inhibiting proliferation, migration and invasion of osteosarcoma cells by targeting MAPK7

Yu Hou, Helin Feng, Jianbao Jiao, Ligang Qian, Bo Sun, Pingtao Chen, Qinggui Li, Zhixing Liang

Abstract

Objective To investigate the effects of miR-143-3p and MAPK7 on the proliferation, migration, and invasion of U2OS human osteosarcoma (OS) cells.Methods The expression of miR-143-3p and MAPK7 in U2OS cells were detected by qRT-PCR, and the protein level of MAPK7 was measured by western blot assay. The targeting relationship between miR-143-3p and MAPK7 was predicted by TargetScan and verified by dual luciferase reporter assay. MTT and Transwell assays were used to detect cell viability, migrated cells and invaded cells of U2OS cells.Results Compared with hFOB1.19 cells, the expression of miR-143-3p was down-regulated and MAPK7 was up-regulated in U2OS cells. Cell viability, migration and invasion ability significantly decreased induced by miR-143-3p overexpression or MAPK7 knockdown in U2OS cells. The results of dual luciferase reporter assay indicated that miR-143-3p interacted with MAPK7. Furthermore, overexpression of MAPK7 could reverse the inhibitory effects on cell proliferation, migration and invasion in U2OS cells induced by miR-143-3p mimics.Conclusion miR-143-3p could inhibit proliferation, migration and invasion of U2OS cells by targeting MAPK7.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: MicroRNA in disease regulation · Cancer-related molecular mechanisms research · Circular RNAs in diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Orthopedics, Affiliated Hospital of Hebei University

Department of Orthopedics, Fourth Hospital of Hebei Medical University

Funding

Natural Science Foundation of Hebei Province · Key Project of Medical-Science Research of Hebei Province

References (24)

Show source-provided references
1. 10.1007/s40744-016-0050-210.1007/s40744-016-0050-2 ↗
2. 10.1111/ajco.1234610.1111/ajco.12346 ↗
3. 10.1016/j.ocl.2015.08.02210.1016/j.ocl.2015.08.022 ↗
4. 10.2217/imt-2016-004810.2217/imt-2016-0048 ↗
5. 10.1186/s13045-016-0373-z10.1186/s13045-016-0373-z ↗
6. Kumar RR, Boro A, Fuchs B. Involvement and clinical aspects of microRNA in osteosarcoma. Int J Mol Sci. 2016;17:1–8.
7. 10.1038/nrd.2016.24610.1038/nrd.2016.246 ↗
8. Sun X, Dai G, Yu L, et al. miR-143-3p inhibits the proliferation, migration and invasion in OS by targeting FOSL2. Sci Rep. 2018;8:1–10.
9. 10.5483/BMBRep.2017.50.11.17910.5483/BMBRep.2017.50.11.179 ↗
10. 10.1093/nar/gkw55010.1093/nar/gkw550 ↗
11. 10.17219/acem/6291510.17219/acem/62915 ↗
12. 10.1007/s13402-017-0341-910.1007/s13402-017-0341-9 ↗
13. 10.7150/jca.1506110.7150/jca.15061 ↗
14. Lin W, Lin W, Wang L, et al. Analysis of miR-148b expression differences in stage-I and II parosteal osteosarcoma. Oncol Lett. 2018;16:998–1002.
15. 10.3892/ol.2016.538810.3892/ol.2016.5388 ↗
16. Wang L, He J, Xu H, et al. MiR-143 targets CTGF and exerts tumour-suppressing functions in epithelial ovarian cancer. Am J Transl Res. 2016;8:2716–2726.
17. 10.18632/oncotarget.1867110.18632/oncotarget.18671 ↗
18. 10.1002/jcb.2615810.1002/jcb.26158 ↗
19. Li D, Hu J, Song H, et al. miR-143-3p targeting LIM domain kinase 1 suppresses the progression of triple-negative breast cancer cells. Am J Transl Res. 2017;9:2276–2285.
20. 10.2174/092986732466617020312342710.2174/0929867324666170203123427 ↗
21. 10.5858/arpa.2015-0475-RS10.5858/arpa.2015-0475-RS ↗
22. 10.18632/oncotarget.1290810.18632/oncotarget.12908 ↗
23. 10.1186/s12885-015-1455-y10.1186/s12885-015-1455-y ↗
24. 10.1002/mc.2242010.1002/mc.22420 ↗